Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Henry Khederian

Why Jazz Pharmaceuticals Shares Are Rising

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) shares are trading higher by 10.5% at $151.00 after the company reported better-than-expected fourth-quarter EPS and sales results.

Jazz Pharmaceuticals reported quarterly earnings of $4.21 per share which beat the analyst consensus estimate of $3.63. Jazz Pharmaceuticals also reported quarterly sales of $896.73 million which beat the analyst consensus estimate of $865.88 million by 4%. This is a 35% increase over sales of $665.52 million the same period last year.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.